The Newest Alzheimer’s Drugs Might Be Worthless, Review Finds

The Newest Alzheimer’s Drugs Might Be Worthless, Review Finds

Tackling Alzheimer’s disease might be even harder than assumed. A report out today casts serious doubt on the latest drugs approved to treat the fatal neurodegenerative condition. Researchers examined the clinical trial data surrounding anti-amyloid medications for...